ReviewRadiologie (Heidelberg, Germany)2023
[Risk-minimizing tube current modulation for computed tomography].
Review in Radiologie (Heidelberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 0 citations in OpenAlex.
- Personalized eye protection for head CT organ-based tube current modulation: A deep learning approach to derive 3D eyeball models from a single-view topogram.Journal of applied clinical medical physics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aim/problemEvery computed tomography (CT) examination is accompanied by radiation exposure. The aim is to reduce this as much as possible without compromising image quality by using a tube current modulation technique. STANDARD PROCEDURE: CT tube current modulation (TCM), which has been in use for about two decades, adjusts the tube current to the patient's attenuation (in the angular and z‑directions) in a way that minimizes the mAs product (tube current-time product) of the scan without compromising image quality. This mAsTCM, present in all CT devices, is associated with a significant dose reduction in those anatomical areas that have high attenuation differences between anterior-posterior (a.p.) and lateral, particularly the shoulder and pelvis. Radiation risk of individual organs or of the patient is not considered in mAsTCM. METHODOLOGICAL INNOVATION: Recently, a TCM method was proposed that directly minimizes the patient's radiation risk by predicting organ dose levels and taking them into account when choosing tube current. It is shown that this so-called riskTCM is significantly superior to mAsTCM in all body regions. To be able to use riskTCM in clinical routine, only a software adaptation of the CT system would be necessary.
conclusionsWith riskTCM, significant dose reductions can be achieved compared to the standard procedure, typically around 10%-30%. This is especially true in those body regions where the standard procedure shows only moderate advantages over a scan without any tube current modulation at all. It is now up to the CT vendors to take action and implement riskTCM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.